TBI-2001

Autologous CD19-specific CAR T cells · University Health Network

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TBI-2001, covering 2025-07-02 to 2025-07-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLL [Phase 1]

See pricing